Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nalbuphine Hydrochloride Injection

Approval Number

国药准字H20213884

Company扬子江药业集团江苏紫龙药业有限公司

Registration Date

November 24, 2021

Drug Information

Generic Name

盐酸纳布啡注射液

Dosage Form

注射剂

Strength

1ml:20mg

Drug Type

化学药品

Registration Date

November 24, 2021

Company Information

Applicant Company

Company Name扬子江药业集团江苏紫龙药业有限公司

Company Address

常州市新北区薛家镇云河西路9号

Manufacturing Company

Company Name扬子江药业集团江苏紫龙药业有限公司

Company Address

江苏省常州市新北区薛家镇云河西路9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy